BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 9482525)

  • 1. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.
    Pritsch O; Maloum K; Dighiero G
    Semin Oncol; 1998 Feb; 25(1):34-41. PubMed ID: 9482525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity and B-cell malignancies.
    Dighiero G
    Verh Dtsch Ges Pathol; 1996; 80():148-59. PubMed ID: 9020570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity and B-cell malignancies.
    Dighiero G
    Hematol Cell Ther; 1998 Feb; 40(1):1-9. PubMed ID: 9556183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the B lymphocyte proliferating in B-CLL and in other B-cell malignancies is frequently committed to production of natural autoantibodies.
    Dighiero G; Borche L
    Nouv Rev Fr Hematol (1978); 1990; 32(5):323-6. PubMed ID: 2099404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An attempt to explain disordered immunity and hypogammaglobulinemia in B-CLL.
    Dighiero G
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):283-8. PubMed ID: 3065729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity.
    Ghia P; Scielzo C; Frenquelli M; Muzio M; Caligaris-Cappio F
    Autoimmun Rev; 2007 Dec; 7(2):127-31. PubMed ID: 18035322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
    Diehl LF; Ketchum LH
    Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin genes in chronic lymphocytic leukemia.
    Kipps TJ
    Blood Cells; 1993; 19(3):615-25; discussion 631-2. PubMed ID: 8018942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunologic aspects of B chronic lymphocytic leukemia associated with autoimmune disorders.
    Duek A; Shvidel L; Braester A; Berrebi A
    Isr Med Assoc J; 2006 Dec; 8(12):828-31. PubMed ID: 17214095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apparently opposite postulates of Ehrlich (Horror autotoxicus) and Metchnikoff (physiological autoimmunization) are not irreconcilable].
    Dighiero G
    Bull Acad Natl Med; 1999; 183(6):1153-63; discussion 1163-4. PubMed ID: 10560169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD5 links humoral autoimmunity with B-cell chronic lymphocytic leukemia.
    Mankai A; Bordron A; Renaudineau Y; Berthou C; Ghedira I; Youinou P
    Expert Rev Clin Immunol; 2007 May; 3(3):333-41. PubMed ID: 20477677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.
    Pangalis GA; Angelopoulou MK; Vassilakopoulos TP; Siakantaris MP; Kittas C
    Semin Hematol; 1999 Apr; 36(2):104-14. PubMed ID: 10319379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune complications of chronic lymphocytic leukemia.
    Hamblin TJ
    Semin Oncol; 2006 Apr; 33(2):230-9. PubMed ID: 16616070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Kyasa MJ; Parrish RS; Schichman SA; Zent CS
    Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro production of anti-RBC antibodies and cytokines in chronic lymphocytic leukemia.
    Barcellini W; Montesano R; Clerici G; Zaninoni A; Imperiali FG; Calori R; Cortelezzi A; Zanella A
    Am J Hematol; 2002 Nov; 71(3):177-83. PubMed ID: 12410572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
    Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
    Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
    Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
    J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire.
    Schroeder HW; Dighiero G
    Immunol Today; 1994 Jun; 15(6):288-94. PubMed ID: 7520700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Apoptosis in chronic lymphocytic leukemia].
    Giordano M
    Medicina (B Aires); 2000; 60 Suppl 2():12-6. PubMed ID: 11188924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement.
    Melo JV; Foroni L; Brito-Babapulle V; Luzzatto L; Catovsky D
    Clin Exp Immunol; 1988 Jul; 73(1):23-8. PubMed ID: 3262465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.